Bioresorbable Polymers Market
PUBLISHED: 2023 ID: SMRC23330
SHARE
SHARE

Bioresorbable Polymers Market

Bioresorbable Polymers Market Forecasts to 2030 - Global Analysis By Product Type (Polysaccharides, Polylactic acid, Polyglycolic acid, Polycaprolactone and Other Product Types), Application (Orthopedic devices, Drug delivery and Other Applications), and By Geography

4.6 (78 reviews)
4.6 (78 reviews)
Published: 2023 ID: SMRC23330

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $1.52 BN

Projected Year Value (2030)

US $4.23 BN

CAGR (2023 - 2030)

15.7%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America


According to Stratistics MRC, the Global Bioresorbable Polymers Market is accounted for $1.52 billion in 2023 and is expected to reach $4.23 billion by 2030 growing at a CAGR of 15.7% during the forecast period. Bioresorbable polymers are substance that is frequently utilised in the healthcare industry because it may be safely absorbed by the body. When these polymers are planted on the body, they do not need to be dethatched. Moreover, the utilization of the Bioresorbable polymers in the healthcare industry breaks down bioresorbable polymers such polylactide (PLA), polyglycolide (PGA), and copolymers of PLA/PGA. For the non-structural drug delivery to resorbable screws and anchors, these materials may be customised to match mechanical performance and resorption rates which drive the growth of the market.



Market Dynamics:

Driver:

Favourable reimbursement

One of the main factors propelling the expansion of the bioresorbable polymers market is the favourable reimbursement status for a number of surgical procedures. For instance, the US CMS offers the worldwide surgical package, which aims to cover payments for all surgical treatments which includes preoperative, intraoperative, and postoperative carried out by surgeons for US citizens. As a result, the market for bioresorbable polymers is anticipated to develop over the next few years as a result of the rising number of surgical operations brought on by better insurance coverage.

Restraint:

Lack of skilled personnels

Due to developments in this area, the technical landscape and applications for medical goods based on bioresorbable materials are developing quickly. This urges doctors and other healthcare professionals to have the skills necessary to manage medicinal goods made of bioresorbable materials. As a result, sophisticated bioresorbable medical items are not used for wound closure by medical surgeons or doctors from healthcare services.

Opportunity:

Increasing demand for bioresorbable polymers for drug delivery applications

By permitting cyclic dosing, controlled release of therapeutic agents in constant amounts throughout time, and different releases of both hydrophilic and hydrophobic medications, polymers have considerably improved drug delivery technology. Since its early days of using ordinary materials, the field has substantially grown. Modern breakthroughs in drug delivery are now built on the rational design of polymers intended to exert unique biological activities and tailored for a particular cargo. Bioresorbable polymers have the capacity to change surfaces with ligands for privacy and targeted drug administration in the human body. They also allow regulated release to the desired place, stability to unbalanced molecules (such as proteins), and stability to imbalanced molecules.

Threat:

High cost when compared to traditional plastics

The market for bioresorbable polymers is severely constrained by the higher cost of bioresorbable polymers compared to degradable and other polymers. Although the market anticipates a faster pace of development, it is still smaller than the market for traditional polymers. As a result, the manufacturing of traditional polymers benefits from economies of scale, whereas the production of bioresorbable polymers is small-scale. As a result, the cost of production is greater, boosting demand for the finished product. Bioresorbable polymers, however, provide a one-time fix and improved services overall. Long-term, this can lessen the impact of these polymers' greater cost.

Covid-19 Impact

The epidemic has had an impact on almost every facet of civilization. The market for bioresorbable polymers has seen a downturn as a result of the interruptions in the global supply chain and the delays in planned processes. The medical industry's declining demand was the root of this problem. Raw resources were scarce, and it took longer for goods to get where they were going. But when the demand for bioresorbable polymers was raised in the medical and pharmaceutical sectors, the market for them began to rebound. The medical sector continued to function during the epidemic, supporting the world market. Following the start of the widespread vaccination campaign in 2021, additional developing countries expanded the manufacture of bioresorbable polymers.

The polylactic acid segment is expected to be the largest during the forecast period

The polylactic acid segment is estimated to have a lucrative growth, due to its excellent process ability and mechanical strength, PLA is one of the most commercially viable biopolymers. PLA is non-toxic, biodegradable, recyclable, compostable, and is metabolised by living things. It is superior to conventional polymers in a number of ways, including improved thermal processability and the ability to be processed through a variety of moulding processes. The two primary subtypes of PLA are PLLA and PDLLA.

The orthopedic devices segment is expected to have the highest CAGR during the forecast period

The orthopedic devices segment is anticipated to witness the highest CAGR growth during the forecast period, due to the major use of resorbable polymers is in orthopaedics. The high growth in this application is attributed to a number of factors, including an increase in the prevalence of orthopaedic disorders, an improvement in standard of living brought on by rising per capita income, rising healthcare spending, a rise in the demand for higher quality medical care, and increased awareness of bioresorbable stents in numerous nations around the world.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rapid economic expansion of developing nations and rising per capita disposable income. The presence of high-growth economies like India, China, and Japan, as well as the quick ageing of the population, the rising number of hospitals, supportive reimbursement policies, the implementation of helpful government initiatives, rising per capita income, significant investments in the healthcare sector, demand for cutting-edge surgery products, and the expansion of private hospitals into rural areas are additional factors driving the market in APAC.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to rising product use in orthopaedics and medication delivery applications. The bioresorbable polymers market in North America is further fueled by the U.S., which serves as a significant centre for research and development in the healthcare sector. Additionally, it is anticipated that the expanding need for polymers in orthopaedics and drug delivery applications, together with rising healthcare spending, would drive up demand for the product in the area the expanding need for polymers in orthopaedics and drug delivery applications, as well as more healthcare spending, are all expected to drive up product demand in this region.



Key players in the market

Some of the key players profiled in the Bioresorbable Polymers Market include Evonik Industries AG, Foster Corporation, Ashland Global Holdings Inc., REVA Medical, LLC, Bezwada Biomedical, LLC, BMG Incorporated, Foryou Medical Devices Co., Ltd, Musashino Chemical Laboratory, Ltd., Henan Xinghan Biotechnology Co. Ltd., KLS Martin Group, DSM Biomedical, Corbion N.V., Zeus Industrial Products, Abbott, 3D Biotek LLC, Sunstar Suisse S.A. and Futerro

Key Developments:

In June 2023, Evonik launches new TEGO® Rad 2550 slip and defoamer additive for radiation-curing inks and coatings, The new TEGO® Rad 2550 is a clear, low viscosity liquid that effectively reduces static and dynamic surface tension in both conventional UV- and LED-cured formulations.

In June 2023, Evonik expands global alkoxides business with new Singapore plant. In future, alkoxide catalysts will also play a bigger role in the circular economy through their use in the chemical recycling of PET plastics.

Product Types Covered:
• Polysaccharides
• Polylactic acid
• Polyglycolic acid
• Polycaprolactone
• Poly(lactic-co-glycolic acid) (PLGA)
• Agro-Polymers
• Bio-Polyesters
• Other Product Types

Applications Covered:
• Orthopedic devices
• Drug delivery
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Bioresorbable Polymers Market, By Product Type
5.1 Introduction
5.2 Polysaccharides
5.3 Polylactic acid
5.3.1 Poly-d,l-lactic acid (PDLLA)
5.3.2 Poly (l-lactic) acid (PLLA)
5.4 Polyglycolic acid
5.5 Polycaprolactone
5.6 Poly(lactic-co-glycolic acid) (PLGA)
5.7 Agro-Polymers
5.8 Bio-Polyesters
5.9 Other Product Types

6 Global Bioresorbable Polymers Market, By Application
6.1 Introduction
6.2 Orthopedic devices
6.2.1 Hip
6.2.2 Knee
6.2.3 Trauma
6.2.4 Spine
6.3 Drug delivery
6.3.1 Parenteral
6.3.2 Oral
6.3.3 Other Drug deliveries
6.4 Other Applications

7 Global Bioresorbable Polymers Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Evonik Industries AG
9.2 Foster Corporation
9.3 Ashland Global Holdings Inc.
9.4 REVA Medical, LLC
9.5 Bezwada Biomedical, LLC
9.6 BMG Incorporated
9.7 Foryou Medical Devices Co., Ltd
9.8 Musashino Chemical Laboratory, Ltd.
9.9 Henan Xinghan Biotechnology Co. Ltd.
9.10 KLS Martin Group
9.11 DSM Biomedical
9.12 Corbion N.V.
9.13 Zeus Industrial Products
9.14 Abbott
9.15 3D Biotek LLC
9.16 Sunstar Suisse S.A.
9.17 Futerro

List of Tables
1 Global Bioresorbable Polymers Market Outlook, By Region (2021-2030) ($MN)
2 Global Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
4 Global Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
5 Global Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
6 Global Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
7 Global Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
8 Global Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
9 Global Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
10 Global Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
11 Global Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
12 Global Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
13 Global Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
14 Global Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
15 Global Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
16 Global Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
17 Global Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
18 Global Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
19 Global Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
20 Global Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
21 Global Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
22 Global Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
23 Global Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
24 North America Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
25 North America Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
26 North America Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
27 North America Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
28 North America Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
29 North America Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
30 North America Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
31 North America Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
32 North America Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
33 North America Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
34 North America Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
35 North America Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
36 North America Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
37 North America Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
38 North America Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
39 North America Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
40 North America Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
41 North America Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
42 North America Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
43 North America Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
44 North America Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
45 North America Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
46 North America Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
47 Europe Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
48 Europe Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
49 Europe Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
50 Europe Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
51 Europe Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
52 Europe Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
53 Europe Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
54 Europe Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
55 Europe Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
56 Europe Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
57 Europe Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
58 Europe Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
59 Europe Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
60 Europe Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
61 Europe Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
62 Europe Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
63 Europe Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
64 Europe Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
65 Europe Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
66 Europe Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
67 Europe Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
68 Europe Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
69 Europe Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
70 Asia Pacific Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
71 Asia Pacific Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
72 Asia Pacific Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
73 Asia Pacific Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
74 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
75 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
76 Asia Pacific Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
77 Asia Pacific Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
78 Asia Pacific Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
79 Asia Pacific Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
80 Asia Pacific Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
81 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
82 Asia Pacific Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
83 Asia Pacific Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
84 Asia Pacific Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
85 Asia Pacific Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
86 Asia Pacific Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
87 Asia Pacific Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
88 Asia Pacific Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
89 Asia Pacific Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
90 Asia Pacific Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
91 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
92 Asia Pacific Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
93 South America Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
94 South America Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
95 South America Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
96 South America Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
97 South America Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
98 South America Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
99 South America Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
100 South America Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
101 South America Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
102 South America Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
103 South America Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
104 South America Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
105 South America Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
106 South America Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
107 South America Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
108 South America Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
109 South America Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
110 South America Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
111 South America Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
112 South America Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
113 South America Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
114 South America Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
115 South America Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)
116 Middle East & Africa Bioresorbable Polymers Market Outlook, By Country (2021-2030) ($MN)
117 Middle East & Africa Bioresorbable Polymers Market Outlook, By Product Type (2021-2030) ($MN)
118 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polysaccharides (2021-2030) ($MN)
119 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polylactic acid (2021-2030) ($MN)
120 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly-d,l-lactic acid (PDLLA) (2021-2030) ($MN)
121 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly (l-lactic) acid (PLLA) (2021-2030) ($MN)
122 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polyglycolic acid (2021-2030) ($MN)
123 Middle East & Africa Bioresorbable Polymers Market Outlook, By Polycaprolactone (2021-2030) ($MN)
124 Middle East & Africa Bioresorbable Polymers Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2021-2030) ($MN)
125 Middle East & Africa Bioresorbable Polymers Market Outlook, By Agro-Polymers (2021-2030) ($MN)
126 Middle East & Africa Bioresorbable Polymers Market Outlook, By Bio-Polyesters (2021-2030) ($MN)
127 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Product Types (2021-2030) ($MN)
128 Middle East & Africa Bioresorbable Polymers Market Outlook, By Application (2021-2030) ($MN)
129 Middle East & Africa Bioresorbable Polymers Market Outlook, By Orthopedic devices (2021-2030) ($MN)
130 Middle East & Africa Bioresorbable Polymers Market Outlook, By Hip (2021-2030) ($MN)
131 Middle East & Africa Bioresorbable Polymers Market Outlook, By Knee (2021-2030) ($MN)
132 Middle East & Africa Bioresorbable Polymers Market Outlook, By Trauma (2021-2030) ($MN)
133 Middle East & Africa Bioresorbable Polymers Market Outlook, By Spine (2021-2030) ($MN)
134 Middle East & Africa Bioresorbable Polymers Market Outlook, By Drug delivery (2021-2030) ($MN)
135 Middle East & Africa Bioresorbable Polymers Market Outlook, By Parenteral (2021-2030) ($MN)
136 Middle East & Africa Bioresorbable Polymers Market Outlook, By Oral (2021-2030) ($MN)
137 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Drug deliveries (2021-2030) ($MN)
138 Middle East & Africa Bioresorbable Polymers Market Outlook, By Other Applications (2021-2030) ($MN)

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials